FRANCISCO JAVIER
SALMERÓN ESCOBAR
Forscher in der Zeit 2002-2020
Hospital Universitario Virgen de las Nieves
Granada, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Universitario Virgen de las Nieves (28)
2022
-
Non-pharmacologic direct cost of a simplified strategy with glecaprevir/pibrentasvir for 8 weeks in naïve non-cirrhotic patients with hepatitis C implemented in clinical practice. The Just SIMPLE Study
Gastroenterologia y Hepatologia, Vol. 45, Núm. 5, pp. 342-349
2021
-
In Patients With Obesity, the Number of Adipose Tissue Mast Cells Is Significantly Lower in Subjects With Type 2 Diabetes
Frontiers in Immunology, Vol. 12
2020
2019
2015
-
Effectiveness and safety of first-generation protease inhibitors in clinical practice: Hepatitis C virus patients with advanced fibrosis
World Journal of Gastroenterology, Vol. 21, Núm. 30, pp. 9163-9174
-
Hepatotoxicity from the consumption of herbalist products by a paediatric population
Nutricion Hospitalaria, Vol. 32, Núm. 2, pp. 652-655
2013
2011
-
Factors associated with hepatic steatosis in obese children and adolescents
Journal of Pediatric Gastroenterology and Nutrition, Vol. 53, Núm. 2, pp. 196-201
-
Importance of host genetic factors HLA and IL28B as predictors of response to pegylated interferon and ribavirin
American Journal of Gastroenterology, Vol. 106, Núm. 7, pp. 1246-1254
2005
-
Drug-induced liver injury: An analysis of 461 incidences submitted to the Spanish registry over a 10-year period
Gastroenterology, Vol. 129, Núm. 2, pp. 512-521
2004
-
HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease
Hepatology, Vol. 39, Núm. 6, pp. 1603-1612
2001
-
Liver fibrosis assessment with semiquantitative indexes and image analysis quantification in sustained-responder and non-responder interferon-treated patients with chronic hepatitis C
Journal of Hepatology, Vol. 34, Núm. 5, pp. 740-747
1999
-
Acute liver injury associated with the use of ebrotidine, a new H2- receptor antagonist
Journal of Hepatology, Vol. 31, Núm. 4, pp. 641-646
1996
-
Epidemiology, serological markers, and hepatic disease of anti-HCV ELISA-2-positive blood donors
Digestive Diseases and Sciences, Vol. 41, Núm. 10, pp. 1933-1938
-
Estudio multicentrico retrospectivo de la eficacia del interferon alfa en la hepatitis cronica C
Medicina Clinica, Vol. 107, Núm. 18, pp. 689-692
-
HIPOTIROIDISMO PERMANENTE TRAS TRATAMIENTO CON INTERFERON ALFA EN LA HEPATITIS CRONICA C
Medicina Clinica
-
Hepatitis C virus genotypes
Gastroenterología y hepatología, Vol. 19, Núm. 5, pp. 274-280
1995
-
Prospective study of the incidence of post-transfusion hepatitis after the exclusion of donors positive for anti-HCV ELISA 2
Medicina clínica, Vol. 105, Núm. 17, pp. 641-644
-
TRATAMIENTO ALTERNATIVO AL INTERFERON EN LA HEPATITIS CRONICA VIRAL
Gastroenterologia y Hepatologia, Vol. 18, Núm. 8, pp. 430-436
1994
-
Analysis of hepatitis B precore region in serum and liver of chronic hepatitis B virus carriers
Journal of Hepatology, Vol. 21, Núm. 3, pp. 353-360